Šiaurės Makedonija – Farmacijos produktai – Lijekovi 4
Aprašymas
Vaistai gydyti sklerozę su daugiafazėmis
**TED Notice**
**2023/S 000-000000**
**Direct award of a contract**
**Results of the negotiated procedure**
**Section I: Contracting authority**
**I.1) Name and addresses**
Official name: European Commission, Directorate-General for Health and Food Safety
Postal address: Rue de la Loi 200, 1049 Brussels
Country: Belgium
**I.2) Joint procurement**
The contract is awarded by a central purchasing body
**I.3) Communication**
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://etendering.ec.europa.eu
Additional information can be obtained from the abovementioned address
**I.4) Type of the contracting authority**
European institution/agency or international organisation
**I.5) Main activity**
Health
**Section II: Object**
**II.1) Scope of the procurement**
II.1.1) Title: Procurement of medicines for the treatment of multiple sclerosis
II.1.2) Main CPV code:
33650000
II.1.3) Type of contract:
Supplies
II.1.4) Short description:
The European Commission is seeking to award a contract for the supply of medicines for the treatment of multiple sclerosis. The contract will be awarded to a single supplier.
II.1.5) Estimated total value
Value excluding VAT: 50 000 000.00 EUR
Currency: EUR
II.1.6) Information about lots
This contract is divided into lots: no
**II.2) Description**
II.2.1) Title:
II.2.2) Additional CPV code(s):
33651000
33651100
33651200
33651300
II.2.3) Place of performance:
II.2.4) Description of the procurement:
The European Commission intends to award a contract for the supply of medicines for the treatment of multiple sclerosis. The contract will be awarded to a single supplier.
The medicines to be supplied include, but are not limited to:
- Interferon beta-1a (Rebif®)
- Interferon beta-1b (Betaferon®/Extavia®)
- Glatiramer acetate (Copaxone®)
- Natalizumab (Tysabri®)
- Fingolimod (Gilenya®)
- Dimethyl fumarate (Tecfidera®)
- Teriflunomide (Aubagio®)
- Alemtuzumab (Lemtrada®)
- Ocrelizumab (Ocrevus®)
- Cladribine (Mavenclad®)
The total quantity of medicines to be supplied is estimated to be 50 000 000.00 EUR.
**Section IV: Procedure**
**IV.1) Description**
IV.1.1) Type of procedure:
Negotiated procedure without prior publication of a call for competition
IV.1.2) Limitations on the number of operators who may participate in the procedure or on the number of solutions or offers requested:
IV.1.3) Place of conclusion of the contract:
IV.1.4) Type of the contract award procedure:
Best price-quality ratio
**IV.2) Administrative information**
IV.2.1) Previous publication(s) concerning the same contract:
Notice number in the OJ S: 2023/S 000-000000
IV.2.2) Time limit for receipt of tenders or requests to participate:
Date: 21/01/2023
Local time: 12:00
IV.2.3) Estimated date of dispatch of invitations to selected candidates to confirm interest:
Date: 22/01/2023
IV.2.4) Languages in which tenders or requests to participate may be submitted:
English
IV.2.5) Minimum time period during which the tenderer must maintain the tender:
Duration in months: 6 (from the date of dispatch of invitations to selected candidates to confirm interest)
**Section V: Award of contract**
**V.1) Award of contract**
On 20/01/2023, the contract was awarded to:
Official name: Company X
Postal address: Address X
Country: Country X
The contract has a duration of 48 months.
**V.2) Information on value of the contract**
Total value of the contract: 50 000 000.00 EUR
Currency: EUR
**V.3) Additional information**
The contract was awarded following a negotiated procedure without prior publication of a call for competition, in accordance with Article 32 of Directive 2014/24/EU.
CPV kodai
Dokumentai ir pateikimas
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Susiję pirkimai
North Macedonia – Medical consumables – surgical consumables
PHI Clinical Hospital ShtipŠiaurės MakedonijaMedical consumablesDeadline per 26 dienasPublikuota 2026-11-19
North Macedonia – Infusion solutions – Infusion solutions
PHI Clinical Hospital ShtipŠiaurės MakedonijaInfusion solutionsDeadline per 26 dienasPublikuota 2026-11-18
North Macedonia – Anaesthetics – Medicines from the list of medicines covered by the Health Insurance Fund
Public Health General Hospital StrumicaŠiaurės MakedonijaAnaestheticsAntiepilepticsAnalgesicsDeadline per 4 dienasPublikuota 2026-11-17
North Macedonia – Various medicinal products – Procurement of Microbiological Tests
PHI Institute of Public Health of Republic of North Macedonia SkopjeŠiaurės MakedonijaVarious medicinal productsLaboratory reagentsDyes and pigmentsDeadline per 19 dienasPublikuota 2026-11-16